Healthcare Stakeholders Ask CMS Not to Limit Access to NGS Hereditary Cancer Risk Tests
The diversity of the organizations that have signed the letter to CMS demonstrates widespread concern over this policy.
CMS Holding Off Market-Based Payment for Labs Until 2018; Tweaks Criteria for Labs Reporting Pricing
CMS gave labs an additional year to gear up for the implementation of the Protecting Access to Medicare Act of 2014 and clarified key programmatic definitions.
Amid Competing LDT Regulatory Proposals, Common Ground but Key Disagreements for Congress to Consider
Multiple legislative proposals before Congress show regulation of lab-developed tests remains divisive within the life sciences community.
People in the News: Kapa Biosystems Adds New Managers; Cepheid's Bishop to Chair AdvaMedDx Board
Kapa Biosystems said this week that it has added four new managers as part of the company's expansion, which included moving and in
AdvaMedDx announced this week that it has elected John Bishop, CEO of Cepheid, as the new chair of its board of directors. Before joining Cepheid in 2002, he was CEO and president of Vysis.
Jun 5, 2013